Table 2.
Diagnosed hepatic, gallbladder, and pancreatic diseases among chronic obstructive pulmonary disease cases and controls
| Cases (n = 2284) | Controls (n = 5959) | P value | |
|---|---|---|---|
| Total patients with any hepatic diagnosis* (070.x, 570−573.x) | 25 (1.09) | 66 (1.11) | 0.96 |
| Viral hepatitis including hepatitis A, B, or C (070.x) | 10 (0.44) | 30 (0.50) | 0.67 |
| Acute and subacute hepatic necrosis (570.x) | 0 (0.00) | 2 (0.03) | 0.38 |
| Alcohol-related liver diseases (571.1−0.3) | 4 (0.18) | 11 (0.18) | 0.93 |
| Non-alcohol related liver diseases (571.4−0.9) | 10 (0.44) | 32 (0.54) | 0.57 |
| Abscess and other liver infections (572.0, 572.1, 573.1−573.3) | 4 (0.18) | 8 (0.13) | 0.75 |
| All gallbladder disease including cholelithiasis (574.x−576.x) | 63 (2.76) | 97 (1.63) | <0.001 |
| All pancreatic disease (577.x) | 32 (1.40) | 36 (0.60) | <0.001 |
Notes: Values expressed as the number of patients and percent (cases/100) of the chronic obstructive pulmonary disease cases or controls.
*
Patients may have more than one specific hepatic diagnosis.